Scholarlink

<p>The use of a&#xa0;beta-blocker has been an integral part of treatment following myocardial infarction for decades. However, some of the studies on which this treatment recommendation is based were carried out half a&#xa0;century ago. In the meantime, the widespread establishment of coronary reperfusion in particular has fundamentally changed the treatment of acute myocardial infarction. For patients with preserved systolic left ventricular function, the benefit of beta-blocker therapy following myocardial infarction can currently no longer be clearly demonstrated. This review summarizes the evidence for beta-blocker therapy from the pre-coronary reperfusion era to the present era of coronary reperfusion.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Betablocker nach Myokardinfarkt ohne Herzinsuffizienz – Stellenwert in der Ära der koronaren Reperfusion

  • 期刊论文

  • 发表日期：

    2025年10月29日

查看全文
  • Samuel Lee,
  • Stephan Baldus

摘要

The use of a beta-blocker has been an integral part of treatment following myocardial infarction for decades. However, some of the studies on which this treatment recommendation is based were carried out half a century ago. In the meantime, the widespread establishment of coronary reperfusion in particular has fundamentally changed the treatment of acute myocardial infarction. For patients with preserved systolic left ventricular function, the benefit of beta-blocker therapy following myocardial infarction can currently no longer be clearly demonstrated. This review summarizes the evidence for beta-blocker therapy from the pre-coronary reperfusion era to the present era of coronary reperfusion.